Literature DB >> 16386736

Bi-directional regulation of emodin and quercetin on smooth muscle myosin of gizzard.

Hou-Li Zhang1, Ze-Yao Tang, Jing-Xian Yang, Ying Zhang, Yue Li, Yuan Lin.   

Abstract

This study is to reveal the characteristics of bidirectional regulation of emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) and quercetin on gizzard smooth muscle myosin. Our results indicate that: (a) emodin demonstrates stimulatory effects, and quercetin produces inhibitory effects on myosin phosphorylation and Mg(2+)-ATPase activities of Ca(2+)/calmodulin-dependent phosphorylated myosin in a dose-dependent manner; (b) a combination of emodin and quercetin enhances phosphorylation and Mg(2+)-ATPase activities for partially phosphorylated myosin and inhibits those activities for fully phosphorylated myosin; (c) 1-(5-Chloronaphthalene-1-sulfonyl)-1H2-hexahydro-1,4-diazepine inhibits myosin phosphorylation in the presence of emodin and/or quercetin. A combination of emodin and quercetin indicates its potential for modulating gastric-intestinal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386736     DOI: 10.1016/j.febslet.2005.12.041

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons.

Authors:  J-D Xu; S Liu; W Wang; L-S Li; X-F Li; Y Li; H Guo; T Ji; X-Y Feng; X-L Hou; Y Zhang; J-X Zhu
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  The synergism mechanism of Rhubarb Anthraquinones on constipation elucidated by comparative pharmacokinetics of Rhubarb extract between normal and diseased rats.

Authors:  Xiao-Hong Gong; Yan Li; Ruo-Qi Zhang; Xiao-Fang Xie; Cheng Peng; Yun-Xia Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-07-05       Impact factor: 2.441

Review 3.  Myosin Light Chain Kinase: A Potential Target for Treatment of Inflammatory Diseases.

Authors:  Yongjian Xiong; Chenou Wang; Liqiang Shi; Liang Wang; Zijuan Zhou; Dapeng Chen; Jingyu Wang; Huishu Guo
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.